Beta-blockers for atrial fibrillation: must we consider asymptomatic arrhythmias?
- 26 June 2000
- journal article
- editorial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 36 (1), 147-150
- https://doi.org/10.1016/s0735-1097(00)00676-8
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillationJournal of the American College of Cardiology, 2000
- Dofetilide in Patients with Congestive Heart Failure and Left Ventricular DysfunctionNew England Journal of Medicine, 1999
- Rhythm Management in Atrial Fibrillation—With a Primary Emphasis on Pharmacologic Therapy: Part 3Pacing and Clinical Electrophysiology, 1998
- Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA studyPacing and Clinical Electrophysiology, 1998
- Treatment of Atrial Fibrillation and Paroxysmal Supraventricular Tachycardia With BidisomideCirculation, 1997
- The incidence of asymptomatic paroxysmal atrial fibrillation in patients treated with propranolol or propafenoneInternational Journal of Cardiology, 1996
- Management of Patients With Atrial FibrillationCirculation, 1996
- Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.Circulation, 1994
- Propafenone Treatment of Symptomatic Paroxysmal Supraventricular ArrhythmiasAnnals of Internal Medicine, 1991
- Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.Circulation, 1989